Report cover image

Oral Proteins and Peptides Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War

Publisher Prodture
Published Aug 02, 2024
Length 148 Pages
SKU # PROD19315553

Description

Oral Proteins and Peptides Market: Global Market Size, Forecast, Insights, Segmentation, and Competitive Landscape with Impact of COVID-19 & Russia-Ukraine War


The global oral proteins and peptides market is expected to grow at a CAGR of around 26.1% during 2025-2034. This report on global oral proteins and peptides market report provides holistic understanding of the market along with market sizing, forecast, drivers, challenges, and competitive landscape. The report presents a clear picture of the global oral proteins and peptides market by segmenting the market based on drug type, product type, application, end user, and region. Also, detailed profiles of companies operating in the oral proteins and peptides market are provided in this report. We believe that this report will aid the professionals and industry stakeholders in making informed decision.

Market Drivers

• Rise in Patient Preference for Oral Drugs
• Rising Demand for Effective Drugs and Product Type

Market Challenges

• High Cost
• Low Availability of the Product

Historical & Forecast Period

Base Year: 2024
Historical Period: 2020-2024
Forecast Period: 2025-2034

Market by Drug Type

• Linaclotide
• Plecanatide
• Calcitonin
• Insulin
• Octreotide

Market by Product Type

• Low Molecular Weight Iron Dextran
• Ferric Gluconate
• Iron Sucrose
• Ferric Carboxyl Maltose

Market by Application

• Gastric and Digestive Disorders
• Bone Diseases
• Diabetes
• Hormonal Disorders
• Others

Market by End User
• Hospital
• Pharmaceutical Company
• Others

Market by Region

• Europe
Germany
United Kingdom
France
Italy
Spain
Russia
Netherlands
Rest of Europe
• North America
United States
Canada
• Asia Pacific
China
Japan
India
South Korea
Australia
Indonesia
Rest of Asia Pacific
• Latin America
Mexico
Brazil
Argentina
Rest of Latin America
• Middle East & Africa
Saudi Arabia
Turkey
Iran
United Arab Emirates
Rest of Middle East & Africa

Table of Contents

148 Pages
1. Preface
1.1 Objective
1.2 Target Audience & Key Offerings
1.3 Report’s Scope
1.4 Research Methodology
1.4.1 Phase I
1.4.2 Phase II
1.4.3 Phase III
1.5 Assumptions
2. Key Insights
3. Global Oral Proteins and Peptides Market
3.1. Introduction
3.2. Market Drivers
3.3. Market Challenges
4. Global Oral Proteins and Peptides Market Analysis
4.1. Market Portraiture
4.2. Market Size
4.3. Market Forecast
4.4. Impact of COVID-19
4.5. Impact of Russia-Ukraine War
5. Global Oral Proteins and Peptides Market by Drug Type
5.1. Introduction
5.2. Linaclotide
5.3. Plecanatide
5.4. Calcitonin
5.5. Insulin
5.6. Octreotide
6. Global Oral Proteins and Peptides Market by Product Type
6.1. Introduction
6.2. Low Molecular Weight Iron Dextran
6.3. Ferric Gluconate
6.4. Iron Sucrose
6.5. Ferric Carboxyl Maltose
7. Global Oral Proteins and Peptides Market by Application
7.1. Introduction
7.2. Gastric and Digestive Disorders
7.3. Bone Diseases
7.4. Diabetes
7.5. Hormonal Disorders
7.6. Others
8. Global Oral Proteins and Peptides Market by End User
8.1. Introduction
8.2. Hospital
8.3. Pharmaceutical Company
8.4. Others
9. Global Oral Proteins and Peptides Market by Region
9.1. Introduction
9.2. Europe
9.2.1. Germany
9.2.2. United Kingdom
9.2.3. France
9.2.4. Italy
9.2.5. Spain
9.2.6. Russia
9.2.7. Netherlands
9.2.8. Rest of the Europe
9.3. North America
9.3.1. United States
9.3.2. Canada
9.4. Asia Pacific
9.4.1. China
9.4.2. Japan
9.4.3. India
9.4.4. South Korea
9.4.5. Australia
9.4.6. Indonesia
9.4.7. Rest of the Asia Pacific
9.5. Latin America
9.5.1. Mexico
9.5.2. Brazil
9.5.3. Argentina
9.5.4. Rest of Latin America
9.6. Middle East & Africa
9.6.1. Saudi Arabia
9.6.2. Turkey
9.6.3. Iran
9.6.4. United Arab Emirates
9.6.5. Rest of Middle East & Africa
10. SWOT Analysis
11. Porter’s Five Forces
12. Market Value Chain Analysis
13. Competitive Landscape
13.1. Competitive Scenario
13.2. Company Profiles
13.2.1. AbbVie Inc.
13.2.2. Allergan Plc.
13.2.3. AstraZeneca PLC
13.2.4. Bayer AG
13.2.5. Biocon Limited
13.2.6. Chiasma Inc.
13.2.7. Diabetology Ltd.
13.2.8. Generex Biotechnology Corp.
13.2.9. Novo Nordisk A/S
13.2.10. Oramed Pharmaceuticals Inc.
13.2.11. Pfizer Inc.
13.2.12. Proxima Concepts Limited (Diabetology Ltd.)
13.2.13. Sanofi
13.2.14. Synergy Pharmaceuticals Inc.
13.2.15. Tarsa Therapeutics Inc.
List of Figures
Figure 1: Global Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 2: Global Oral Proteins and Peptides Market by Drug Type, 2024
Figure 3: Global Oral Proteins and Peptides Market by Product Type, 2024
Figure 4: Global Oral Proteins and Peptides Market by Application, 2024
Figure 5: Global Oral Proteins and Peptides Market by End User, 2024
Figure 6: Global Oral Proteins and Peptides Market by Region, 2024
Figure 7: Global Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 8: Global Oral Proteins and Peptides Market by Drug Type (in %), 2024 & 2034
Figure 9: Global Linaclotide Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 10: Global Linaclotide Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 11: Global Plecanatide Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 12: Global Plecanatide Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 13: Global Calcitonin Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 14: Global Calcitonin Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 15: Global Insulin Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 16: Global Insulin Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 17: Global Octreotide Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 18: Global Octreotide Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 19: Global Oral Proteins and Peptides Market by Product Type (in %), 2024 & 2034
Figure 20: Global Low Molecular Weight Iron Dextran Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 21: Global Low Molecular Weight Iron Dextran Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 22: Global Ferric Gluconate Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 23: Global Ferric Gluconate Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 24: Global Iron Sucrose Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 25: Global Iron Sucrose Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 26: Global Ferric Carboxyl Maltose Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 27: Global Ferric Carboxyl Maltose Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 28: Global Oral Proteins and Peptides Market by Application (in %), 2024 & 2034
Figure 29: Global Gastric and Digestive Disorders Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 30: Global Gastric and Digestive Disorders Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 31: Global Bone Diseases Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 32: Global Bone Diseases Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 33: Global Diabetes Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 34: Global Diabetes Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 35: Global Hormonal Disorders Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 36: Global Hormonal Disorders Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 37: Global Other Applications Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 38: Global Other Applications Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 39: Global Oral Proteins and Peptides Market by End User (in %), 2024 & 2034
Figure 40: Global Hospital Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 41: Global Hospital Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 42: Global Pharmaceutical Company Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 43: Global Pharmaceutical Company Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 44: Global Other End Users Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 45: Global Other End Users Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 46: Global Oral Proteins and Peptides Market by Region (in %), 2024 & 2034
Figure 47: Europe Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 48: Europe Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 49: Europe Oral Proteins and Peptides Market by Country (in %), 2024 & 2034
Figure 50: Germany Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 51: United Kingdom Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 52: France Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 53: Italy Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 54: Spain Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 55: Russia Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 56: Netherlands Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 57: North America Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 58: North America Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 59: North America Oral Proteins and Peptides Market by Country (in %), 2024 & 2034
Figure 60: United States Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 61: Canada Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 62: Asia Pacific Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 63: Asia Pacific Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 64: Asia Pacific Oral Proteins and Peptides Market by Country (in %), 2024 & 2034
Figure 65: China Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 66: Japan Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 67: India Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 68: South Korea Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 69: Australia Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 70: Indonesia Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 71: Latin America Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 72: Latin America Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 73: Latin America Oral Proteins and Peptides Market by Country (in %), 2024 & 2034
Figure 74: Mexico Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 75: Brazil Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 76: Argentina Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 77: Middle East & Africa Oral Proteins and Peptides Market (in US$ Million), 2020-2024
Figure 78: Middle East & Africa Oral Proteins and Peptides Market (in US$ Million), 2025-2034
Figure 79: Middle East & Africa Oral Proteins and Peptides Market by Country (in %), 2024 & 2034
Figure 80: Saudi Arabia Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 81: Turkey Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 82: Iran Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 83: UAE Oral Proteins and Peptides Market (in US$ Million), 2020-2034
Figure 84: Market Value Chain
List of Tables
Table 1: Global Oral Proteins and Peptides Market Portraiture
Table 2: Global Oral Proteins and Peptides Market by Drug Type (in US$ Million), 2024 & 2034
Table 3: Global Oral Proteins and Peptides Market by Product Type (in US$ Million), 2024 & 2034
Table 4: Global Oral Proteins and Peptides Market by Application (in US$ Million), 2024 & 2034
Table 5: Global Oral Proteins and Peptides Market by End User (in US$ Million), 2024 & 2034
Table 6: Global Oral Proteins and Peptides Market by Region (in US$ Million), 2024 & 2034
Table 7: Europe Oral Proteins and Peptides Market by Country (in US$ Million), 2024 & 2034
Table 8: North America Oral Proteins and Peptides Market by Country (in US$ Million), 2024 & 2034
Table 9: Asia Pacific Oral Proteins and Peptides Market by Country (in US$ Million), 2024 & 2034
Table 10: Latin America Oral Proteins and Peptides Market by Country (in US$ Million), 2024 & 2034
Table 11: Middle East & Africa Oral Proteins and Peptides Market by Country (in US$ Million),
2024 & 2034
Table 12: List of Key Players

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us